Axogen, Inc. — Director's Dealing 2020

Sep 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-09-15

Reporting Person: Freitag Gregory Gene (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Common Stock	M	13046	$3.67	Acquired	244530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-15	Common Stock	$3.67	M	9000	Disposed	2021-12-29	Common Stock (9000)	Direct
2020-09-15	Common Stock	$3.67	M	4046	Disposed	2021-12-29	Common Stock (4046)	Direct

Footnotes

F1: This Form is being filed to report the cash exercise of stock options for a total of 13,046 shares.